{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:13Z","timestamp":1786112773174,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Heterozygous mutations in the gene encoding HtrA serine protease 1 (HTRA1) can cause autosomal dominant cerebral small-vessel disease (CSVD), presenting with clinical features that differ slightly from other hereditary CSVD subtypes. Only a limited number of cases have been documented globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 51-year-old man presented with more than 2 years of left lower limb weakness, which had acutely worsened over the preceding day. Brain magnetic resonance imaging (MRI) revealed ischemic demyelinating changes in the white matter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Genetic sequencing identified a heterozygous HTRA1 mutation. Follow-up testing confirmed that both of his daughters also carried the same heterozygous mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Management focused on secondary prevention, risk-factor control, and lifestyle modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>A 6-month follow-up cranial MRI showed no new lesions, and the patient remained clinically stable without disease progression during 1 year of monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Heterozygous HTRA1 mutations may present as autosomal-dominant CSVD, and genetic testing is central to establishing the diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048528","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:02:28Z","timestamp":1778745748000},"page":"e48528","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Autosomal dominant inheritance of a heterozygous mutation in HTRA1: A case report and literature review"],"prefix":"10.1097","volume":"105","author":[{"given":"Jianzhong","family":"Shu","sequence":"first","affiliation":[{"name":"Encephalopathy Department, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-0943","authenticated-orcid":false,"given":"Jinrong","family":"Li","sequence":"additional","affiliation":[{"name":"Encephalopathy Department, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"349","DOI":"10.17219\/acem\/131216","article-title":"Cerebral small vessel disease: a review.","volume":"30","author":"Chojdak-\u0141ukasiewicz","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2024.01.001","article-title":"CADASIL: A NOTCH3-associated cerebral small vessel disease.","volume":"66","author":"Yuan","year":"2024","journal-title":"J Adv Res"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/CM9.0000000000001176","article-title":"HTRA1-related autosomal dominant cerebral small vessel disease.","volume":"134","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1002\/jcp.29609","article-title":"HTRA1 expression profile and activity on TGF-\u03b2 signaling in HTRA1 mutation carriers.","volume":"235","author":"Fasano","year":"2020","journal-title":"J Cell Physiol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"e6632","DOI":"10.1590\/1414-431x20176632","article-title":"Heterozygous HTRA1 missense mutation in CADASIL-like family disease.","volume":"51","author":"Wu","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fneur.2020.00545","article-title":"HTRA1-related cerebral small vessel disease: a review of the literature.","volume":"11","author":"Uemura","year":"2020","journal-title":"Front Neurol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10072-022-06454-5","article-title":"Clinical features and pathogenicity assessment in patients with HTRA1-autosomal dominant disease.","volume":"44","author":"He","year":"2023","journal-title":"Neurol Sci"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"e24174","DOI":"10.1002\/jcla.24174","article-title":"A novel heterozygous HTRA1 mutation in an Asian family with CADASIL-like disease.","volume":"36","author":"Cao","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/IJGM.S404813","article-title":"Heterozygous pathogenic and likely pathogenic symptomatic HTRA1 variant carriers in cerebral small vessel disease.","volume":"16","author":"Xu","year":"2023","journal-title":"Int J Gen Med"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/brain\/awab271","article-title":"Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic.","volume":"144","author":"Coste","year":"2021","journal-title":"Brain"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s44161-024-00492-2","article-title":"Redefining common and rare HTRA1 variants as risk factors for polyvascular disease.","volume":"3","author":"Debette","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/aian.aian_174_24","article-title":"CADASIL Type 2 (HTRA1 Cerebral Small Vessel Disease) in an Indian Woman.","volume":"27","author":"Maramattom","year":"2024","journal-title":"Ann Indian Acad Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:09Z","timestamp":1785945669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":12,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048528","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}